Development of an indirect ELISA for the serological diagnosis of dourine.

This study introduces the development of an indirect ELISA for diagnosing dourine, a parasitic disease in horses. The test is suggested to be an improvement on existing diagnostic methods like CFT, and other tests, as it showed a sensitivity and specificity of 100% in this particular research.

Introduction to Dourine and the Diagnostic Challenge

• Dourine is a venereal disease in horses caused by the parasite T. equiperdum.
• Diagnosing this condition is complex. On top of clinical history and examination, pathological and serological findings are necessary to provide an accurate diagnosis.
• The Complement Fixation Test (CFT) is a standard test recommended by the Office International des Epizooties (OIE) for dourine, which is part of the criteria for international trade of horses. However, it’s known to produce inconsistent or nonspecific reactions in some healthy horses.

Development of the Indirect ELISA

• In response to the flaws in the current testing methods, the researchers in this study developed a new test, the Indirect Enzyme Linked Immunosorbent Assay (iELISA).
• iELISA is suggested as a method to confirm positive serological (antibody) detection of dourine or to resolve inconclusive results from previous tests like CFT, IFAT, and cIB.
• The researchers used sera samples from horses, both negative and positive for dourine (according to usages of CFT and IFAT) to evaluate the functionality of the iELISA method.

Results and Conclusions

• The research found that the optimum cut-off value determined a sensitivity and specificity of 100% for the iELISA test. This means that it correctly identified all true positive and true negative cases, demonstrating high precision and accuracy.
• Moreover, one sample that was low-positive in CFT and negative by IFAT, tested positive with iELISA, possibly indicating a higher sensitivity of iELISA compared to the other methods.
• In conclusion, the researchers propose that the iELISA and cIB tests may be used in cases where other serological methods give doubtful or inconclusive results, either as alternative or as additional confirmatory tests.